HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 22, No 01, January 2018 – Weighing the options       » Scientists close in on origin of SARS       » Chinese researchers map key protein in DNA repair with near-atomic resolution       » Ryzodeg reduces hypoglycaemia in type 2 diabetic fasting patients       » United States cancer drug costs increasing despite competition       » Eating yogurt may help reduce chronic inflammation in women      
EYE ON CHINA
Ineffective baby vaccines by two companies recalled
Vaccines which immunize against diphtheria, pertussis (whooping cough) and tetanus were ineffective in its immunization effect but were not life-threatening.

More than 650,000 doses of a vaccine routinely given to newborns in China have been recalled after testing showed they were ineffective.

The problem with the vaccine, which immunizes against diphtheria, pertussis (whooping cough) and tetanus, was identified after batches were distributed in Shandong and Hebei provinces and in Chongqing.

Some doses were administered before the recall, "which might diminish the immunization effect but will not threaten people's health", the China Food and Drug Administration said in a statement on 3 November.

The recall relates to batches from two companies: Changsheng Biotechnology in Jilin province, which sent 252,600 doses to Shandong; and the Wuhan Institute of Biological Products in Hubei province, which sent 190,520 doses to Chongqing and 210,000 doses to Hebei.

Under the Drug Administration Law, vaccines must be checked for safety and efficacy before they can enter the market.

The National Institutes for Food and Drug Control, which carries out premarket checks, tested the DPT vaccines according to normal international practice, and reported no issues, the FDA said. However, the ineffective vaccines were not identified. A later routine check found the vaccines' "titer" - a measure of the concentration of antibodies-of both companies' products to be substandard.

Investigative teams have been sent to check compliance at the companies' production bases and will spend six to eight weeks testing the quality of all vaccines.

The National Health and Family Planning Commission and provincial health departments have also sent experts to assess stocks of the vaccine to ensure that routine immunization programs continue.

After the DPT vaccine was incorporated into China's immunization program in the 1970s, the rates of diphtheria, pertussis and tetanus have fallen steadily, according to the FDA.

"There has been no diphtheria cases reported since 2007, and the annual incidence of pertussis has dropped to less than 0.5 per 100,000 people now, compared with 100 to 200 per 100,000 in the 1970s," the statement said.

Source: China Daily

Click here for the complete issue.

NEWS CRUNCH  
news Biology of Ageing II - Impactful Interventions
news Separation of conjoined twins presents surgical and ethical challenges for MassGeneral Hospital for Children staff
news MIT Technology Review announces 2018's 10 'Innovators Under 35 Asia'
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Addressing the ageing population / Clinical trials
March:
Nutrition / Women in Science
April:
Digestive health / Intellectual property
May:
Asthma / Dental health
June:
Oncology / Biotech landscape in APAC
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy